Novel Suppressive Effects of Ketotifen on Migration and Invasion of MDA-MB-231 and HT-1080 Cancer Cells |
Kim, Hyun Ji
(BK21PLUS R-FIND Team, College of Pharmacy, Dongguk University)
Park, Mi Kyung (BK21PLUS R-FIND Team, College of Pharmacy, Dongguk University) Kim, Soo Youl (National Cancer Center) Lee, Chang Hoon (BK21PLUS R-FIND Team, College of Pharmacy, Dongguk University) |
1 | Aspenstrom, P. (2004) Integration of signalling pathways regulated by small GTPases and calcium. Biochim. Biophys. Acta 1742, 51-58. DOI |
2 | Bravo-Cordero, J. J., Hodgson, L. and Condeelis, J. (2012) Directed cell invasion and migration during metastasis. Curr. Opin. Cell Biol. 24, 277-283. DOI |
3 | Bray, K., Gillette, M., Young, J., Loughran, E., Hwang, M., Sears, J. C. and Vargo-Gogola, T. (2013) Cdc42 overexpression induces hyperbranching in the developing mammary gland by enhancing cell migration. Breast Cancer Res. 15, R91. DOI |
4 | Brinckerhoff, C. E. and Matrisian, L. M. (2002) Matrix metalloproteinases: a tail of a frog that became a prince. Nat.Rev. Mol. Cell Biol. 3, 207-214. DOI ScienceOn |
5 | Cailleau, R., Young, R., Olive, M. and Reeves, W. J., Jr. (1974) Breast tumor cell lines from pleural effusions. J. Natl. Cancer Inst. 53, 661-674. DOI |
6 | Cricco, G., Nunez, M., Medina, V., Garbarino, G., Mohamad, N., Gutierrez, A., Cocca, C., Bergoc, R., Rivera, E. and Martin, G. (2006) Histamine modulates cellular events involved in tumour invasiveness in pancreatic carcinoma cells. Inflamm.Res. 55 Suppl 1, S83-84. DOI |
7 | Ellenbroek, S. I. and Collard, J. G. (2007) Rho GTPases: functions and association with cancer. Clin. Exp. Metastasis 24, 657-672. DOI |
8 | Elliott, R. L. (2012) Four lessons from global health drug discovery: medicine for an ailing industry? ACS Med. Chem. Lett. 3, 688-690. DOI |
9 | Ferry, G., Boutin, J. A., Hennig, P., Genton, A., Desmet, C., Fauchere, J. L., Atassi, G. and Tucker, G. C. (1998) A zinc chelator inhibiting gelatinases exerts potent in vitro anti-invasive effects. Eur. J. Pharmacol. 351, 225-233. DOI |
10 | Geiser, A. G., Anderson, M. J. and Stanbridge, E. J. (1989) Suppression of tumorigenicity in human cell hybrids derived from cell lines expressing different activated ras oncogenes. Cancer Res. 49, 1572-1577. |
11 | Friedl, P. and Wolf, K. (2003) Tumour-cell invasion and migration: diversity and escape mechanisms. Nat. Rev. Cancer 3, 362-374. DOI ScienceOn |
12 | Fritz, G., Brachetti, C., Bahlmann, F., Schmidt, M. and Kaina, B. (2002) Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br.J. Cancer 87, 635-644. DOI |
13 | Fritz, G., Just, I. and Kaina, B. (1999) Rho GTPases are over-expressed in human tumors. Int. J.Cancer 81, 682-687. DOI ScienceOn |
14 | Gommerman, J. L. and Berger, S. A. (1998) Protection from apoptosis by steel factor but not interleukin-3 is reversed through blockade of calcium influx. Blood 91, 1891-1900. |
15 | Grahnen, A., Lonnebo, A., Beck, O., Eckernas, S. A., Dahlstrom, B. and Lindstrom, B. (1992) Pharmacokinetics of ketotifen after oral administration to healthy male subjects. Biopharm. Drug Dispos. 13, 255-262. DOI ScienceOn |
16 | Gschwandtner, M., Purwar, R., Wittmann, M., Baumer, W., Kietzmann, M., Werfel, T. and Gutzmer, R. (2008) Histamine upregulates keratinocyte MMP-9 production via the histamine H1 receptor. J. Invest. Dermatol. 128, 2783-2791. DOI |
17 | Gupta, S. C., Sung, B., Prasad, S., Webb, L. J. and Aggarwal, B. B. (2013) Cancer drug discovery by repurposing: teaching new tricks to old dogs. Trends Pharmacol. Sci. 34, 508-517. DOI |
18 | Jung, K. H., Park, B. H. and Hong, S. S. (2012) Progress in cancer therapy targeting c-Met signaling pathway. Arch. Pharm. Res. 35, 595-604. DOI |
19 | Kobayashi, K., Matsumoto, S., Morishima, T., Kawabe, T. and Okamoto, T. (2000) Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression. Cancer Res. 60, 3978-3984. |
20 | Kim, H. R., Kim, J. M., Kim, M. S., Hwang, J. K., Park, Y. J., Yang, S. H., Kim, H. J., Ryu, D. G., Lee, D. S., Oh, H., Kim, Y. C., Rhee, Y. J., Moon, B. S., Yun, J. M., Kwon, K. B. and Lee, Y. R. (2014) Saussurea lappa extract suppresses TPA-induced cell invasion via inhibition of NF-kappaB-dependent MMP-9 expression in MCF-7 breast cancer cells. BMC Complement. Altern. Med. 14, 170. DOI |
21 | Mazzocca, A. and Carloni, V. (2009) The metastatic process: methodological advances and pharmacological challenges. Curr. Med. Chem. 16, 1704-1717. DOI |
22 | Meng, F., Han, Y., Staloch, D., Francis, T., Stokes, A. and Francis, H. (2011) The H4 histamine receptor agonist, clobenpropit, suppresses human cholangiocarcinoma progression by disruption of epithelial mesenchymal transition and tumor metastasis. Hepatology 54, 1718-1728. DOI |
23 | Medina, V., Croci, M., Crescenti, E., Mohamad, N., Sanchez-Jimenez, F., Massari, N., Nunez, M., Cricco, G., Martin, G., Bergoc, R. and Rivera, E. (2008) The role of histamine in human mammary carcinogenesis: H3 and H4 receptors as potential therapeutic targets for breast cancer treatment. Cancer Biol. Ther. 7, 28-35. DOI |
24 | Medina, V. A. and Rivera, E. S. (2010) Histamine receptors and cancer pharmacology. Br. J. Pharmacol. 161, 755-767. DOI ScienceOn |
25 | Mendoza, M. and Khanna, C. (2009) Revisiting the seed and soil in cancer metastasis. Int. J. Biochem. Cell Biol. 41, 1452-1462. DOI ScienceOn |
26 | Pacharn, P. and Vichyanond, P. (2013) Immunomodulators for conjunctivitis. Curr. Opin. Allergy Clin. Immunol. 13, 550-557. DOI |
27 | Rasheed, S., Nelson-Rees, W. A., Toth, E. M., Arnstein, P. and Gardner, M. B. (1974) Characterization of a newly derived human sarcoma cell line (HT-1080). Cancer 33, 1027-1033. DOI |
28 | Park, M. K., Jo, S. H., Lee, H. J., Kang, J. H., Kim, Y. R., Kim, H. J., Lee, E. J., Koh, J. Y., Ahn, K. O., Jung, K. C., Oh, S. H., Kim, S. Y. and Lee, C. H. (2013) Novel suppressive effects of cardamonin on the activity and expression of transglutaminase-2 lead to blocking the migration and invasion of cancer cells. Life Sci. 92, 154-160. DOI ScienceOn |
29 | Park, M. K. and Lee, C. H. (2011) Alpinia katsumadai suppresses migration and 12-O-tetradecanoylphorbol-13-acetate-induced invasion of HT-1080 cells through suppression of transglutaminase-2, matrix metalloproteinase-2, and matrix metalloproteinase-9 expression. Cancer Prev. Res. 16, 326-332. |
30 | Parri, M. and Chiarugi, P. (2010) Rac and Rho GTPases in cancer cell motility control. Cell Commun. Signal. 8, 23. DOI ScienceOn |
31 | Schwarzer, G., Bassler, D., Mitra, A., Ducharme, F. M. and Forster, J. (2004) Ketotifen alone or as additional medication for long-term control of asthma and wheeze in children. Cochrane Database Syst. Rev. CD001384. |
32 | Soboloff, J. and Berger, S. A. (2002) Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. J. Biol. Chem. 277, 13812-13820. DOI |
33 | Soboloff, J., Zhang, Y., Minden, M. and Berger, S. A. (2002) Sensitivity of myeloid leukemia cells to calcium influx blockade: application to bone marrow purging. Exp. Hematol. 30, 1219-1226. DOI ScienceOn |
34 | Valastyan, S. and Weinberg, R. A. (2011) Tumor metastasis: molecular insights and evolving paradigms. Cell 147, 275-292. DOI ScienceOn |
35 | Zhang, Y., Crump, M. and Berge, S. A. (2002) Purging of contaminating breast cancer cells from hematopoietic progenitor cell preparations using activation enhanced cell death. Breast Cancer Res. Treat. 72, 265-278. DOI |
36 | Xu, D., McKee, C. M., Cao, Y., Ding, Y., Kessler, B. M. and Muschel, R. J. (2010) Matrix metalloproteinase-9 regulates tumor cell invasion through cleavage of protease nexin-1. Cancer Res. 70, 6988-6998. DOI |
37 | Zamboni, W. C., Torchilin, V., Patri, A. K., Hrkach, J., Stern, S., Lee, R., Nel, A., Panaro, N. J. and Grodzinski, P. (2012) Best practices in cancer nanotechnology: perspective from NCI nanotechnology alliance. Clin. Cancer Res. 18, 3229-3241. DOI |
38 | Zhang, Y. and Berger, S. A. (2003) Ketotifen reverses MDR1-mediated multidrug resistance in human breast cancer cells in vitro and alleviates cardiotoxicity induced by doxorubicin in vivo. Cancer Chemother. Pharmacol. 51, 407-414. |
39 | Moore, D. H., Allison, B., Look, K. Y., Sutton, G. P. and Bigsby, R. M. (1997) Collagenase expression in ovarian cancer cell lines. Gynecol. Oncol. 65, 78-82. DOI |
40 | Franzius, D., Hoth, M. and Penner, R. (1994) Non-specific effects of calcium entry antagonists in mast cells. Pflugers Arch. 428, 433-438. DOI |